Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleDermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886).AuthorsBalagula, Yevgeniy; Barth Huston, Katherine; Busam, Klaus; Lacouture, Mario; Chapman, Paul; Myskowski, PatriciaPublicationInvestigational New Drugs, 2011, Vol 29, Issue 5, p1114ISSN0167-6997Publication typeArticleDOI10.1007/s10637-010-9567-3